Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 1

Interventions

Cyclophosphamide 78Rituximab 61Specimen Handling 49Doxorubicin 42Biopsy 42Vincristine 41Magnetic Resonance Spectroscopy 39Prednisone 37fludarabine 29venetoclax 28obinutuzumab 27Methotrexate 23ibrutinib 22Lenalidomide 21Dexamethasone 21Cytarabine 21blinatumomab 19Etoposide 19zanubrutinib 18merphos 17fludarabine phosphate 17acalabrutinib 17prednylidene 15deltacortene 15X-Rays 14Mercaptopurine 14CT-P10 14Bendamustine Hydrochloride 14pegaspargase 13Calcium Dobesilate 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonoscopy × Lymphoid × 30 days × Clear all
NCT05976763 2026-06-02

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
421 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡